MODERATOR(S)
Zain Siddiqui, MD, FRCPC - Penn State Cancer Institute
Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center
session DESCRIPTION
Quick Pitch sessions provide opportunities for presenters to summarize outcomes while highlighting key takeaways from their research in a fast-paced format to present concise takeaways.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
| CAMPEP Credits: | 1.00 |
| MDCB Credits: | 1.00 |
Presentations
-
08:00am - 08:05am ETSpeaker: Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
-
08:00am - 09:00am ETSpeaker: Zain Siddiqui, MD, FRCPC - Penn State Cancer Institute, Hershey
-
08:00am - 09:00am ETSpeaker: Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
-
08:05am - 08:10am ETSpeaker: Janmenjoy Mondal, MD, MBA, MBBS - Medical College and Hospital Kolkata, Kolkata
-
08:10am - 08:15am ET
Consolidation Chemotherapy after Definitive Concurrent Chemoradiotherapy in Patients with Locally Advanced, Inoperable Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Non-inferiority, Phase 3 Trial
Speaker: ChengCheng Fan, MD - Affiliated Cancer Hospital of Zhengzhou university, Zhengzhou -
08:15am - 08:20am ET
Long-Term Survival and Biomarker-Based Exploratory Analysis of Nimotuzumab Combined with SIB-IMRT in Locally Advanced Esophageal Cancer: Insights from a Phase II Clinical Trial
Speaker: Xiaohan Zhao, MD, PhD - The Fourth Hospital of Hebei Medical University, Shijiazhuang -
08:20am - 08:25am ET
Long-Term Outcomes of Image-Guided Proton Therapy for Treatment-Naïve Solitary Hepatocellular Carcinoma Amenable to Surgical Resection or Radiofrequency Ablation: A Pooled Analysis of a Phase II Trial and Prospective Cohort
Speaker: Hiromitsu Iwata, MD, PhD - Nagoya Proton Therapy Center, Nagoya City University West Medical Center, Nagoya -
08:25am - 08:30am ET
Impact of Staging Laparoscopy on Tumor Control and Survival Comparison in Locally Advanced Gastric Cancer after Preoperative Chemoradiation vs. Preoperative Chemotherapy: Data from the Neo-CRAG Phase III Clinical Trial
Speaker: Yujing Zhang, MD, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province -
08:30am - 08:35am ET
Consolidative Camrelizumab Following Definitive Concurrent Chemoradiotherapy In Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase 2 Trial
Speaker: Jun Wang, MD, PhD, RT - Fourth Hospital of Hebei Medical University, Shijiazhuang -
08:35am - 08:55am ETSpeaker: Zain Siddiqui, MD, FRCPC - Penn State Cancer Institute, Hershey
-
08:55am - 09:00am ETSpeaker: Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles